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There is strong experimental evidence that oxidized 
low density lipoprotein (Ox-LDL) plays an important 
role in atherosclerosis. However, the mechanisms by 
which Ox-LDL is formed in vivo are unknown. To test 
whether 15-lipoxygenase (15-LO) could play a role in 
oxidation of LDL by cells, we expressed 15-LO activity in 
murine fibroblasts, which do not normally have 15-LO 
activity, and tested their ability to modify LDL. Using 
a retroviral vector, we prepared fibroblasts that 
expressed 2- to 20-fold more 15-LO activity than 
control fibroblasts infected with a vector containing /3- 
galactosidase (lacZ). Compared with LDL incubated 
with lacZ cells, LDL incubated with 15-LO-containing 
cells were enriched with lipid hydroperoxides. When 
these LDL samples were subsequently subjected to oxi­
dative stress, they were more susceptible to further ox­
idative modification, as judged by increased conjugated 
diene formation and by increased ability to compete 
with 125I-Ox-LDL for uptake by macrophages. These 
findings establish that cellular 15-LO can contribute to 
oxidative modification of LDL, but the quantitative sig­
nificance of these findings to the in vivo oxidation of 
LDL remains to be established.
Oxidatively modified low density lipoprotein (LDL)1- is poten­
tially much more atherogenic than native LDL (1), and there is 
strong evidence that it plays a role in experimental atheroscle­
rosis (2). While a causative role in human atherosclerosis has 
not yet been established, there is indirect evidence to support 
that possibility (reviewed in Refs. 1, 3), A number of clinical 
trials to test the effectiveness of antioxidant supplements in 
the prevention of coronary heart disease are either underway 
or in the planning stages. These studies are predicated on the 
introduction into the LDL particle itself of chain-breaking an­
tioxidants (e,g. vitamin E) that prevent or limit the extent of 
LDL oxidation. If we knew the mechanisms involved in oxida-
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tion of LDL in vivo, i t  should become possible to design novel 
forms of intervention in addition to or instead of the introduc­
tion of antioxidants into LDL, For example, if, as has been 
suggested, 15-lipoxygenase (15-LO) plays a  role in oxidation of 
LDL by cells (4, 5), then the use of appropriate 15-LO inhibitors 
might offer a new complementary mode of treatment, If, on the 
other hand, oxidation in viuo depends on the generation of 
superoxide anion (6-9), interventions th a t inhibit NADPH ox­
idase or other sources of superoxide anion would be of potential 
benefit, as would interventions th a t enhance the activity of 
superoxide dismut as e or other systems quenching the action of 
the superoxide anion. Unfortunately, little or nothing is known 
about the sites and the mechanisms of LDL oxidation in vivo. 
Studies in cell culture allow us to identify a large number of 
candidate systems tha t could participate in oxidative modifica­
tion of LDL. These include not only 15-LO and NADPH oxidase 
but also the P450 system, the mitochondrial electron transport 
chain, myeloperoxidase, cyclooxygenase, and others. From 
studies i?i vitro > it is already clear th a t different cells may 
utilize different systems and th a t individual cell types probably 
use multiple systems in the oxidative modification of LDL. For 
example, monocytes and smooth muscle cells do not express 
15-LO (10), bu t they do oxidatively modify LDL, showing that 
15-LO is not necessary for oxidative modification of LDL. Sim­
ilarly, freshly isolated monocytes express little or no NADPH 
activity, but they can oxidize LDL at a low rate. After activa­
tion to induce expression of NADPH oxidase and the accompa­
nying production of superoxide anion, the rate of LDL oxidation 
is considerably enhanced. Again, the NADPH oxidase system is 
not necessary bu t it  can certainly contribute to oxidative mod­
ification, Secretion of H2Oz by some cells could also play a role 
especially if thiols are concurrently secreted (11, 12). We are 
presently trying to identify which candidate systems are worth 
further study, especially in vivo,
Evidence th a t supports a role of 15-LO in oxidative modi­
fication of LDL can be summarized as follows: 1) purified 
15-lipoxygenases can oxidatively modify LDL in cell-free sys­
tems (4,13-14); 2) oxidation of LDL by endothelial cells and by 
macrophages in culture is suppressed by known inhibitors of 
lipoxygenase (4, 5); 3) tissue samples from atherosclerotic le­
sions, but not from normal aortas, exhibit measurable levels of 
15-LO mRNA and protein (15, 16), as well as 15-LO enzyme 
activity (17); 4) transfer of the 15-LO gene into rabbit iliac 
arteries results in the appearance of epitopes of oxidized LDL 
(18); 5) most importantly, increased amounts of stereospecific 
products of the 15-LO reaction have been demonstrated in 
early atherosclerotic lesions (14) but not in later lesions, where 
non-enzymatic oxidation reactions due to later steps of the 
propagation reactions of lipid peroxidation predominate (19), 
Plowever, interpretation of studies using LO inhibitors must
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be made with caution because most of these inhibitors are also 
nonspecific antioxidants. Consequently, their presence in the 
medium could suppress LDL oxidation and yet that inhibition 
might not be related to inhibition of 15-LO activity. The acety- 
lenic analog of arachadonic acid, eicosatetrayonic acid (ETYA), 
on the other hand, is devoid of nonspecific antioxidant activity, 
but it does inhibit 15-LO activity and LDL oxidation in cultured 
cells (5). Sparrow et al. (20) point out, however, that the con­
centrations needed to inhibit LDL oxidation appear to be much 
higher than the concentrations needed to inhibit 15-LO activ­
ity. Because of this apparent dissociation, they suggested the 
possibility tha t the ETYA inhibition of LDL oxidation might be 
nonspecific, possibly the" result of cell toxicity. Indeed, because 
inhibitors are rarely specific to one and only one target, the use 
of inhibitors to implicate an enzyme system may yield mislead­
ing results. Indeed, ETYA inhibits many other cellular func­
tions as well (21). For these reasons we decided to explore 
further the role of 15-LO in LDL oxidation by expressing 15-LO 
activity in murine fibroblasts, which do not normally express 
15-LO, and to assess the effect of this overexpression on the 
ability of these modified cells to oxidize LDL.
EXPERIMENTAL PROCEDURES
Materials—Electrophoresis grade agarose was obtained from Fischer 
Scientific (Fair Lawn, NJ). Ethidium bromide, Ham’s F-10 medium, 
bovine hematin, and IiEPES-free acid were from Sigma. Geneticin 
(G418) and Dulbecco’B modified Eagle’s (DME) medium (high glucose) 
were both obtained in powdered form from Life Technologies, Inc. RPMI 
1640 medium was from Irvine Scientific (Santa Ana, CA). Ebselen was 
a generous gift of Ciba-Geigy. Restriction endonucleases, formamide, 
and T4 DNA ligase were purchased from Boehringer Mannheim (Mann­
heim, Germany). 2',7'-Dichlorofluorescein diacetate and X-OMAT AR 
film for autoradiography were from Eastm an Kodak (Rochester, NY)* 
o>32P-Labeled dCTP (3000 Ci/mmol) and [l-^Cllinoleic acid (53.0 mCi/ 
mmol) were from New England Nuclear. Fetal bovine serum was pur­
chased from Hyclone (Logan, UT). The Fast-Track mRNA isolation kit 
was obtained from Invitrogen (San Diego, CA). The Prime-a-Gene ran­
dom labeling kit was from Promega (Madison, WI), Magna-Charge 
nylon transfer membranes were from MSI (Westboro, MA), Human 
LDL was isolated from normolipidemic donors (22), and 12RI-LDL was 
prepared by the Iodogen method as described previously (22),
Construction of Retroviral Vector—Human 15-LO cDNA, subcloned 
into the 2?coRI site of the Bluescript KS+ plasmid (Stratagene), was 
kindly provided by Dr. Elliott Si gal (Syntex, Palo Alto, CA) (23). A 
2.2-kb Sall-Bglll cDNA fragment from this plasmid was directi on ally 
sub cloned into the Sail and Bctm-HI (Bglll compatible) sites of the 
retroviral vector pLDRNL, which has been previously described (24), 
Restriction analysis confirmed that the LDL receptor cDNA sequence 
(D) in the retroviral vector was successfully replaced with human 15-LO 
cDNA (LO), and the new vector was subsequently designated 
pLLORNL. 15-LO expression in LLORNL is driven from the long termi­
nal repeat of the Molony murine leukemia virus, and expression of the 
Tn5 neomycin-resi stance gene is driven from an internal Rous sarcoma 
virus long terminal repeat. A second Molony murine leukemia virus 
long terminal repeat provides transcriptional termination sequences.
A parallel construct which contains the j3-galactosidase cDNA (lacZ) 
instead of 15-LO cDNA was designated pLZRNL (25) and was also used 
to produce stably transformed PA317 cells (lacZ cells). Because lacZ 
cells differ from 15-LO cells only in their production of /3'galactosidase 
instead of 15-LO, they were used as controls for the 15-LO cells.
Cell Lines and Culture—Both ecotropic i//2 and amphotropic PA317 
murine fibroblast cell lines were maintained in Dulbecco’s modified 
Eagle’s medium supplemented with 10% fetal bovine serum supple­
mented with glutamine. Cells were plated in 100-mm2 tissue culture 
dishes and grown in humidified incubators with 10% C 02 tension,
Transfection and Infection—ijt2 cells were transfected with plasmids 
pLLORNL (or pLZRNL) using the calcium phosphate co-precipitation 
method as described (24). After allowing 24 h  for packaging and release 
of retroviruses, culture medium was collected, sterile filtered, and ap­
plied to PA317 cells in the presence of polybrene (4 p,g/ml, Sigma). 
Stably transduced cells were selected using the neomycin analog G418 
(400 jLig/ml) and, subsequent to colony or cell line establishment, were 
maintained permanently in the selection medium, Samples from all 
populations were stored under liquid nitrogen for future analysis, and
several clones were chosen for immediate examination.
Northern Analysis and PCR Quantification of 15-LO mRNA 
Expression—Polyadenylated RNA samples from PA317 clones were 
isolated via oligo(dT)-cellulose affinity, using a commercially available 
kit (Invitrogen, San Diego) and were quantified spectrophotometrically. 
Aliquots of poly(A)! RNA ranging from 1 to 10 ju,g were electrophoresed 
in 1.0%/2.2 M formaldehyde gels, capillary-blot transferred onto Mag- 
naCharge nylon transfer membranes (MSI), and hybridized overnight 
with a 32P-labeled human 15-LO cDNA probe (Mstll fragment, 1.6 kb) 
as described (23). Filters were washed sequentially in 1 X SSC, 0,1% 
SDS, 0.5 X SSC, 0.1% SDS, and 0.1 x  SSC, 0.1% SDS (15 min at room 
temperature, each wash: 1 X SSC is 150 m M  NaCl, 15 m M  Na3citrate, 
pH 7.0), dried, and then exposed to film (Kodak X-OMAT AR) for 16 h,
Quantification of 15-LO mRNA in selected PA317 clonal populations 
was performed using competitive polymerase chain reaction amplifica­
tion (26). The oligonucleotide primers used were specific for human 
reticulocyte 15-LO, as described previously (27). Briefly, 100 ng of 
polyiA)* was reverse transcribed, and 10 ng of the product was ampli­
fied with the 15-LO primers for 30 cycles in the presence of a range of 
known concentrations of an internal 15-LO standard which was the 
15-LO cDNA with a 115-bp deletion, PCR products were electropho­
resed and resolved in 8% polyacrylamide gels and then silver-stained. 
The destained gels were dried, photographed, and the intensity of the 
bands quantified on an image processor, When the intensities of both 
bands in the same lane were equal, the concentration of the unknown 
was assumed to be equal to the known concentration of the internal 
standard (26).
Enzymatic Assay of 15-LO Activity—To assay macrophage 15-LO 
activity, [14C]linoleic acid was added to intact cells and, after 30 min, 
the medium was harvested, the lipids extracted, and analyzed for 
[wC113-hydroxy-octadecadienoic acid (13-HODE), as described (5), Be­
cause PA317 cells released almost no 15-LO product to the medium in 
the absence of LDL or other acceptors, assays were done on broken cell 
preparations, PA317 cells were frozen (at -70  °C for 30 min) and 
thawed (at 37 °C for 5 min), and the process was repeated three times, 
The broken cells were then incubated for 30 min with 20-150 nmol of 
[1'1C]linoleic acid (2-4 X IQ3 disintegrations/min/nmol). The medium 
was aspirated, acidified with 1 N HC1, and the lipids extracted with 
methanol/chloroform 1:1 (v/v). Samples were dried under nitrogen and 
resuspended in a minimal volume of methanol/water/acetic acid 90:10:
0,01 (v/v) and stored at -2 0  °C. These samples were then applied to the 
high performance liquid chromatography for separation and analysis 
(5). In addition, control standards (linoleic acid and 13-HODE) were run 
to confirm retention times,
Electrophoretic Assessment of LDL Mobility—LDL (100 /xg/ml) was 
exposed to confluent plates oflacZ or 15-LO cells for varying times, and 
then the media from like samples were pooled and concentrated by 
centrifugal ultrafiltration. Agarose gel electrophoresis was then per­
formed using agarose gels (Universal Gel/8) supplied by Ciba Corning 
Diagnostic Corp as described (22).
Macrophage Degradation—The ability of mouse peritoneal macro­
phages to degrade LDL modified by the lacZ and 15-LO cell clones was 
initially measured as described previously (5, 22). l2BI-LDL was incu­
bated with cells in Ham’s F-10 or in cysteine-free RPMI medium for the 
indicated times, Then aliquots were incubated with freshly plated 
mouse peritoneal macrophages for 5 h  (final concentration 10 /xg of LDL 
protein in 0,5 ml of DME), and then non-iodide, trichloroacetic acid- 
soluble degradation products in the media were determined, Because 
iodination of LDL initiates peroxidation of LDL (22) and complicates 
interpretation of experiments seeking to assess the ability of cells to 
modify LDL, we also performed experiments in which unlabeled LDL 
was used, and the extent of LDL modification was determined by its 
ability to compete with l2DI-ox-LDL for degradation by macrophages. 
For these experiments, 12BI-ox-LDL was incubated with macrophages in 
the absence or presence of LDL that had been pi'eincubated with lacZ or 
15-LO cells and then exposed to further oxidative stress as noted below. 
LDL (200 jLLg/ml) was incubated at 37 °C with lacZ cells or with 15-LO 
cells in cysteine-free RPMI media for 20 h. The media were then diluted 
1:1 with RPMI to yield LDL concentrations of 100 /xg/ml. Aliquots of 
these media were incubated with copper (5 /xm) for 3.5 h and then 25 /xg 
of LDL from the Cu21’ incubations was added to cultures of macro­
phages containing 2.5 jug of 12nI-ox-LDL in DME. The extent of degrada­
tion of the 12BI-ox-LDL tracer was determined after 20 h of incubation,
In other experiments, aliquots of LDL-containing media that had 
been preconditioned by incubation with lacZ or 15-LO cells for 20 h were 
subsequently incubated with cultures of mouse peritoneal macrophages 
in DME/RPMI/(50:50 mixture) for 20 h to effect an oxidative stress 
(instead of exposure to copper as described above). Then aliquots con-
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taming 25 jug of unlabeled LDL were added to a new set of macrophage 
cultures in DME containing 2.5 ¡xg of 12r,I-ox-LDL and extent of degra­
dation of iaoI-ox-LDL determined as described above.
Conjugated Diene Assay—In some experiments, aliquots of the LDL 
preincubated with lacZ or 15-LO cells were subjected to ultracentrifu­
gation to reisolate LDL, dialyzed to remove salts and EDTA, and the 
timfe course of conjugated diene formation determined in the presence of 
2.5 /xM copper as described previously (22).
LOOH and Hydrogen Peroxide Assay—The determination of LOOH/ 
l i 20 2 content in cell-modified LDL was performed according to a mod­
ification of the procedure of Cathcart et al. (28), Briefly, cultured cells 
(lacZ and clone 12) a t 70-80% confluence were incubated with and 
without LDL (100 fig/m 1) at 37 °C for 0-2 h in Hank’s balanced salt 
solution (pH 7.35) containing 6.5 mM glucose. Aliquots of media (<2.5 
fig of protein) were then diluted to final volumes of 1.1 ml with distilled 
water, and 2.9 ml of the indicator substrate/reagent was subsequently 
added to all samples.
In some experiments, hydrogen peroxide (HB0 2) in the media was 
removed by incubating aliquots for 10 min at 37 °C with gentle shaking 
(80 revolutions/min) in the presence of catalase (EC 1,11.1.6) immobi­
lized on 4% agarose beads (2.4 units) (Sigma) which selectively destroys 
H2Oa but not LOOH. Aliquots were chilled to 4 °C, centrifuged at 1,500 
revolutions/min for 5 min to remove immobilized catalase, and aliquots 
(<2,5 ¡xg) of LDL obtained for fluorescencc study. To measure the 
LOOH specifically bound to LDL, modified LDL were reisolated from 
the media as described below.
The indicating reagent was prepared as follows: (i) 2 ml of 0,01 N 
NaOH was added to 0,5 ml of a solution of 2',7'-dichioroiluorescein 
diacetate dissolved in ethanol (1 mM), and after 30 min at room tem­
perature, the reaction solution was diluted with 10 ml of 25 mM sodium 
phosphate buffer (pH 7,2), yielding 2',7'-dichlorofluorescein solution; 
(ii) 1 mg of hematin was dissolved in 0,5 mi of 0.2 N NaOH, diluted with 
100 ml of 25 mM sodium phosphate buffer, and a 14-ml aliquot of this 
hematin solution was boiled for 15 min with 100 ml of 25 mM sodium 
phosphate buffer, yielding an activated hematin solution; and (iii) the 
2',7'-dichloro fluorescein solution (2 ml) and the activated hematin so­
lution were mixed at 4 °C, yielding the indicator reagent, which was 
kept under N2 gas to prevent oxidation.
Reactions between media samples and the indicator reagent were 
carried out at 50 °C for 50 min and, after cooling in a room temperature 
water bath, the fluorescence intensity (excitation -  440 nm, emission 
550 nm) of each sample was measured within 30 min. The standard 
curve for the assay was generated using fluorescence intensities ob­
tained from known quantities (0-2 nmol) of oxidized linoleic acid (1 
/xmol of linoleic acid was dissolved in 1 ml phosphate-buffered saline, 
and oxidized with 500-1000 units of soybean lipoxygenase for 60 min at 
37 °C). The concentrations of oxidized linoleic acid was confirmed in the 
standard samples by monitoring absorbance at 234 nm.
In some experiments, LDL was isolated from the media prior to 
determination of LOOH content according to a modification of the 
procedure of Lynch and Frei (29). In brief, media were subjected to 
concentration by centrifugal ultrafiltration (Amicon) and isolation by 
gel filtration on Sephadex-G25 M columns (PD-10, Pharmacia) equili­
brated with phosphate-buffered saline at a flow rate of 1.2-1,5 ml/min. 
Fractions were collected at 1,5 min and monitored by absorbance at 280 
nm. Total lipids in 0,5-ml aliquots were extracted, according to a mod­
ified procedure of Bligh and Dyer (using 1 ml of CHC1.„ MeOH, and 0.5 
ml of 0.03 N PICl) (30), and the CHC1S layer was dried under N2, 
redissolved in 0,1 ml of MeOH and 0.9 ml of distilled H^O, and used for 
fluorescence measurement. Another aliquot of media was used for de­
termination of protein, which was measured by the procedure of Lowry 
et al, (31),
Ebselen is a seleno-organic compound (2-phenyl-1,2-benzoisoseleno- 
zol-3(2H)-on) that can directly reduce lipoperoxides and can mimic 
glutathione peroxidase (32-34). To further document that the fluores­
cence measured in these experiments was indeed LOOH, we p retreated 
LDL previously incubated with 15-LO cells with ebselen and then 
measurod LOOH fluorescence. Subsequent to its incubation with 15-LO 
cells (clone 12), LDL was reisolated by gel chromatography using PD-10 
columns, concentrated by ultrafiltration, and the protein concentration 
adjusted to 0.5-1 mg/ml with 0,1 m Tris-HCl, 1 mM EDTA, pH 7,4. 
Specific additions of ebselen (added in ethanol) were made, and the 
mixture was then incubated at 37 °C in Tris-HCl/EDTA under nitrogen 
for indicated times, Ebselen was then removed from the incubation by 
gel filtration, and LOOH was measured as described above. In some 
experiments, GSH (3 mM) which enhances the ability of ebselen to 
reduce LOOH (34) was also added.
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Fig. 1. E xpression  o f re tro v ira l RNA by  s tab ly  tran sfo rm ed  
p o p u la tio n s  of LLO R N Lrinfectcd PA317 cells. Left panel, ethidium 
bromide-stained gel containing poly(A) * RNA from PA317 cells infected 
with pLZRNL and pLLORNL, prior to capillary transfer to nitrocellu­
lose membrane, Highl panel, Northern analysis of samples from left 
panel using a randomly labeled, 1.5-kb cDNA probe (Mslll fragment 
from human 15-LO). Lane poly(A)'1 RNA from lacZ-infected clone 
(LZ); lanes 2-4, 15-LO clones 2, 8, and 12, respectively.
RESULTS
Expression o f 15-LO mRNA in Infected PAS 17 Cells—North­
ern analysis, using a radiolabeled 15-LO cDNA probe, detected 
an abundance of intact retroviral poly (A)'1' RNA in cells in­
fected with LLORNL (15-LO cells) (Fig. 1). The size of the 
predominant transcript in all clones examined was 5,7 kb, in 
agreement with prediction. Smaller hybridizing transcripts 
were also visible. Poly (A) 1 ENA isolated from LZRNL infected 
cells (lacZ cells) failed to g iv e  a detectable signal {lane 1). 
Quantitative PCR, utilizing an internal standard, demon­
strated tha t clone 12 expressed approximately «300 copies/cell 
and clones 2 and 8 approximately 163 and 150, respectively.
Expression o f  15-LO Activity in Infected PA317 Cells—To 
detect 15-LO activity in macrophages, we previously used a 
method in which radiolabeled linoleic acid was added to the 
culture medium, and the medium was subsequently assayed 
for the presence of radioactive 13-HODE, a specific product of 
15-LO (5). However, when the 15-LO-infected PA317 cells wore 
assayed in this way, little or no 13-HODE was detected in the 
media (Table I). This could be either because the added linoleic 
acid substrate itself was too rapidly converted into esterified 
lipids or because the 15-LO product was rapidly esterified in 
the cells. Indeed, analysis of lipids from cells incubated with 
[I4C]linoleic acid confirmed th a t almost all of the added free 
fatty acid taken up was rapidly esterified. Therefore, we turned 
to assaying 15-LO activity in broken cell preparations (see 
“Experimental Procedui’es”). We found a 10-20-fold higher 
level of enzyme activity in the 15-LO-infected cell populations 
than in the lacZ-infected control cells (Fig, 2 ), This high activity 
could be reduced 70-90% by the addition of ETYA (1-5 /xm), a 
potent inhibitor of LO activity (data not shown). The differ­
ences in enzyme activity in the three different 15-LO clones 
paralleled the differences in mRNA expression, as determined 
through quantitative PCR analysis (see above). Comparison of 
these results with those previously observed for mouse perito­
neal macrophages is difficult because of the difference in assay 
conditions (i.e. use of intact macrophages). Keeping th a t limi­
tation in mind, clones 2 and 8 dem onstrated 30-50% as much 
15-LO activity, and clone 12 about 2-3-fold more activity than 
peritoneal macrophages.
Increased Content o f Lipid Hydroperoxides in 15-LO 
Clones—The different 15-LO fibroblast clones were incubated
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Table I
Measurement o f 15-LO activity in lacZ and 15-LO cells (clone 12)
Murine fibroblasts were grown to confluence in DME with 10% fetal 
calf serum and glutamine. Cells were washed three times with Ham’s 
F-10. One set of cultures was exposed to three cycles of freezing 
(—70 0C, 15 min) and thawing (37 °C, 5 min). Then, 1 ml of F-10 
containing 20 nmol of [14C]linoleic acid was added to intact and broken 
cells. After 30 min, the media were collected, centrifuged to remove 
cellular debris, and supernatants extracted for determination of [14C]li- 
noleic acid conversion to 13-HODE as described under “Experimental 
Procedures.”
PA 337 done
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Fig. 2 .15-LO activ ity  in  m urine fib rob last c lon es. 15-LO activity 
(in nanomoles of 13-HODE/30 min/dish) was determined in broken cell 
preparations oflacZ and 15-LO cells {clones 2, 8, and 12) and in control 
dishes with no cells {NCC). Results shown are 24 ± S.D, of six separate 
experiments, By analysis of variance, values for lacZ were not different 
from NCC; values of clones 2 and 8 were greater than lacZ (p <  0,04); 
and values for clone 12 greater than clones 2 and 8 (p < 0.0001). Assay 
of 15-LO activity in intact macrophages usually yields values of 20-30 
nmol of 13-H ODE/3G min/dish.
Table II
Total LOOH recovered in cells and in medium after incubation of 
lacZ and 15-LO clone 12 cells for 1 h in the absence or in
the presence of LDL
Cells were incubated for 1 h at 37 °C in 4 ml of Hanks’ balanced salt 
solution in the absence or in the presence of LDL (100 jug/ml). Lipids 
were extracted from media and from cells (washed three times with 
phosphate-buffered saline) and LOOH determined as described under 
“Experimental Procedures.” Results expressed in nanomoles LOOH/ 
well (-0 .4-0.7  mg cell protein/well).
Total LOOH recovered (nmol)
In cells In medium
-LDL +LDL -LDL +LDL Corrected for no cell controls
No cell control ND“ 4.64
LacZ ND ND ND 6.16 1.52
15-LO (clone 12) 0.26 2.32 1.23 15.5 10.9
a ND, not detected.
Table III
Lipoperoxides recovered in medium after 1 and after 2 h of incubation 
of various cell lines, without and with LDL in the medium
Cells were incubated in Hanks’ balanced solution with or without 100 
fxg/ml LDL.
Cell line LDL in medium
Lipoperoxides (nmol/mg cell protein“)
1 h 2 h
Lac Z — 5.5 ± 1.2 (10) 5.4 ± 1,6 (6)
- 1- 6.4 ± 0.7 (28) 17.7 ± 2.1(30)
Clone 12 7.6 ± 0.9 (6) 10.0 ± 0.8 (6)
+ 34.0 ± 3.3 (22) 52.4 ± 5.2 (22)
Clone 2 Hh 14.3 ± 6,3 (12) 11.9 ± 2.0 (12)
Clone 8 + 24.0 ± 1.8 (12) 19.1 ± 3,6(12)
Mouse peritoneal + 239,4 ± 19.2 (6) 431.7 ± 38.1 (6)
macrophages
a Results are expressed as nanomoles of total lipoperoxides in the 
medium at 1 or 2 h. Data presented are experimental values obtained 
after subtraction of no-cell control dishes run in parallel. Values are 
mean ± S.E.; numbers in parentheses indicate the number of individual 
cell incubations conducted.
in Hank’s medium in the absence or presence of LDL for 1 h. 
Media were removed and lipid extracts prepared from both the 
media and the washed cells, and LOOH content determined 
(Table II). In the absence of LDL there was no LOOH detecta­
ble in the media. Only small amounts of LOOH were detected 
in 15-LO cell extracts (clone 12) and none in the lacZ cells. With 
LDL in the medium, LOOH was now readily detectable in the 
15-LO cell extracts, but there was still no detectable LOOH in 
the lacZ cells. The greater abundance of LOOH in 15-LO cells 
incubated with LDL could be due either to provision of sub­
strate or stimulation of 15-LO activity (35), although this latter 
mechanism would have to be of a post-transcriptional nature 
(as the cDNA contains only the coding region of 15-LO).
Increased Content o f LOOH in LDL Incubated with 15-LO 
Clones—One mechanism by which increased 15-LO activity 
within cells might lead to enhanced oxidative modification of 
LDL in the medium would be to seed the LDL w ith lipid 
hydroperoxides, To test this idea we measured lipid hydroper­
oxides in LDL incubated with lacZ or with 15-LO cells. As
a  *
shown in Table II, LDL incubated with clone 12 contained 
2.5-fold more LOOH than  did LDL incubated with lacZ cells 
and up to four times more than the no-cell control. In Table III, 
we show similar studies with all three 15-LO clones and, for 
comparison, with mouse peritoneal macrophages. In these 
studies, values for no-cell controls have been subtracted in 
every case (as in the right column of Table II). After a 1-h 
incubation with LDL, the LOOH in the medium incubated with 
clone 12 cells was about five times greater th an  th a t in the 
medium incubated with lacZ cells. The value a t 2 h (52.4) was
less than twice that at 1 h (34.0). The apparent release from 
mouse pei'itoneal macrophages was more nearly linear, but in 
the clones with lower 15-LO activity (no. 8 and no, 2) the values 
at 2 h were actually lower than the 1-h values, implying re­
uptake or decomposition of LOOH. For this reason, the 1-h 
values may better reflect the initial rate of LOOH release. Note 
that the initial rate of release of LOOH from peritoneal mac­
rophages was more than six times that from the clone 12 cells. 
In several experiments, we passed the media over a PD-10 
column to isolate the LDL (see “Experimental Procedures”) and 
demonstrated tha t when LDL was present, more than 95% of 
the measured LOOH in the medium was associated with LDL,
The fluorometric method used to measure LOOH in these 
studies also detects H20 2. However, when LDL-containing me­
dia were preincubated with catalase bound to agarose, the 
fluorescence yield was not decreased, indicating that almost all 
of the measured fluorescence represented LOOH rather than 
H20 2 (data not shown). Frequently, the apparent LOOH after 
catalase treatment was paradoxically modestly increased, for 
reasons not known. To test whether some of the fluorescence 
might be nonspecific, LDL isolated after incubation with 15-LO 
cells was pretreated with ebselen, an agent known to reduce 
LOOH content (32-34). Ebselen was then removed by gel fil­
tration, and the content of LOOH was determined. As shown in 
Table IV, nearly all of the fluorescence was eliminated by 
pretreatment with 25 pM of ebselen. When ebselen and GSH 
were added together, the elimination of LOOH was greatly 
accelerated (see legend to Table IV).
Oxidative Modification of LDL Assessed in Several Ways
Role of 15-Lipoxygenase in LDL Modification 5195
Table IV
Reduction of LOOH content in LDL by ebselen
LDL was incubated with 15-LO cells (clone 12) for 2 h and then 
reisolated by gel filtration using 0.1 M Tris, 1 m M  EDTA. Indicated 
amounts of ebselen (in absolute ETOH) were added to LDL which was 
then incubated for 5 min at 37 °C and then further incubated under N2 
for the times indicated in the table. At the end of the reactions, ebselen 
was removed by gel filtration and LOOH content determined. Values 
represent the average of two to four determinations for each sample. In 
other experiments, the addition of GSH in addition to the ebselen was 
shown to greatly accelerate LOOH decomposition. Thus, incubation of 
ebselen (25 ¡xu) plus GSH (3 m M ) for only 10 min yielded an LDL with 
only 2.62 nmol of LOOH/mg LDL protein.
Cmo
LOOH in LDL (nmol/mg LDL protein)
Incubation time Nona Ebselen 12.5 25.0
min jU.M
0 34.45 34.45 38.69
3 25.26 15.23
5 30.52 23.21 7.18
10 2 9.26 18.31 4.68
20 3.30
30 24,22 12.63 2.17
after Incubation with 15-LO Cell—Initially, we incubated LDL 
with the 15-LO cells and lacZ control cells for varying periods 
up to 20 h and then performed agarose gel electrophoresis. LDL 
incubated with lacZ cells showed greater mobility than LDL 
incubated in the absence of cells. However, LDL incubated with 
the 15-LO clones did not show any greater increase in mobility 
than lacZ-conditioned LDL (data not shown), We also meas­
ured thiobarbituric acid-re acting substances (TBARS) and 
found similar results, i.e. there was a small increase in TBARS 
for LDL incubated with lacZ cells compared to no-cell control, 
but there was no greater increase in LDL exposed to the dif­
ferent 15-LO clones, including clone 12.
We next tested the ability of the different clones to oxida­
tively modify LDL as measured by enhanced uptake in mac­
rophages. In this set of experiments, I2iT~LDL was incubated 
with lacZ cells or with clone 12 cells for 20 h in either Ham’s 
F-10 or in cysteine-free RPMI and then the rate of degradation 
of the conditioned 125I-LDL by mouse peritoneal macrophages 
was determined (Fig* 3). LDL conditioned by lacZ cells was 
consistently degraded more rapidly than native LDL or LDL 
incubated in the absence of cells. There was a wide range of 
values from experiment to experiment, probably reflecting in 
part the degree of preexisting oxidation of the LDL prepara­
tions used. This in turn is determined importantly by the “age” 
of the LDL preparation and the time between iodination and 
use in the experiment (22). However, the difference between 
clone 12 cells and lacZ cells was highly consistent, being in the 
same direction in every one of 20 separate experiments. Using 
Student’s paired t test, clone 12 displayed a statistically highly 
significant (p < 0.003), nearly 2-fold greater ability to modify 
LDL than did the lacZ cells (Fig. 3).
Consequences of Increased Seeding of LDL with LOOH by 
15-LO Cells—Although the LDL incubated with clone 12 cells 
showed a nearly 2-fold increase in rates of degradation by 
macrophages, this was not nearly proportional to the nearly 
20-fold increase in their 15-LO activity. One possibility is that 
a rate-limiting step is the transfer of LOOH from the cells to 
the LDL and not the rate of LOOH generation within the cells. 
Indeed, the data in Tables II and III show that the initial rate 
of appearance of LOOH in LDL incubated with clone 12 cells 
was only two to three times that for LDL incubated with lacZ 
cells and not 20-fold greater. An LDL with a 2-3-fold increased 
level of LOOH should be more susceptible to further oxidative 
modification when subjected to an additional oxidative stress. 
To test this possibility, we examined the susceptibility of the 
LOOH-enriched LDL (harvested and refloated after a 24-h
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Fig. 3. C apacity o f 15-LO ce lls  to  o x id a tiv e ly  m odify  l25I«LDL.
l2nI-LDL was preincubated with lacZ cells or clone 12 for 20 h, and then 
its rate of degradation by macrophages was determined. Shown are the 
mean values (± S.D.), in jug LDL degraded/5 h/mgcell protein, of results 
obtained in 11 separate experiments conducted in Ham’s F-10 medium 
(□) and 9 separate experiments conducted in cysteine-free RPMI (■). 
Shown also iH the rate of degradation by macrophages of native 
LDL. For all experiments the values were corrected by subtraction of 
degradation products formed in the absence of cells. Macrophage deg­
radation of 15:731-LDL modified by 15-LO clone no. 12 is different from 
that of lacZ in both types of media (p < 0.003, Student’s t test).
incubation) to copper-induced lipid peroxidation in the absence 
of cells as measured by rate of conjugated diene formation 
(Fig. 4), Compared to LDL incubated with lacZ cells, LDL 
incubated with clone 12 cells had the shortest lag time, while 
LDL from clones 2 and 8 had intermediate values, results 
compatible with the observed differences in ‘‘seeding” with
LOOH (Table III).
Another possibility is th a t the 12fT~labeled LDL used in the 
experiments shown in Fig. 3 had already undergone oxidation 
secondary to the radiation (22), and this pro-oxidant effect 
masked small differences in the abilities of cells to further 
oxidize LDL, To tes t this idea, we incubated unlabeled LDL for 
20 h with lacZ cells and with the three different clones of 15-LO 
cells and then subjected each of these LDL samples to a sub­
sequent oxidative stress by incubation with mouse peritoneal 
macrophages (cultured in DME/RPMI a t 1:1 ratio) for 20 h. 
Each LDL was then tested for its ability to compete with 12rT- 
ox-LDL for uptake by a different set of macrophages (Table V). 
In this experiment, under the experimental conditions used, 25 
jitg of unlabeled copper-oxidized LDL was able to compete for 
70% of the uptake of 2.5 ^g of 12r,I-ox-LDL. Twenty-five /xg of 
LDL initially incubated with lacZ cells inhibited degradation of 
ox-LDL by only 8%, but 25 /ng of LDL previously incubated with 
clone 12 inhibited l2r,I-ox-LDL uptake by 71%, i.e. it was just as 
effective as copper-oxidized LDL. Twenty-five fig of LDL con­
ditioned by incubation with clones 2 and 8 yielded intermediate 
values of inhibition.
In another set of experiments, we took unlabeled LDL pre­
conditioned by a 20-h incubation with lacZ cells and 15-LO cells 
and then exposed the conditioned LDL samples to a brief oxi­
dative stress by exposure to copper for 3.5 h in the absence of 
cells. These LDL were then tested for their ability to compete 
with 12fT-ox-LDL for uptake by macrophages (Table VI). In this 
experiment, unlabeled copper-oxidized LDL inhibited uptake of 
12r,I-ox-LDL by 61%, and clone 12-conditioned LDL inhibited 
uptake by 44%, whereas LDL conditioned by incubation with 
clone 2 and 8 inhibited uptake by only 15 and 12%, respec­
tively. LDL from lacZ cells did not inhibit degradation at all, 
Similar results were seen in four other experiments.
It is of interest th a t despite the obvious enhanced suscepti­
bility of LDL conditioned by incubation with clone 12 cells to
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Fig. 4. Tim e course of con jugated  d iene fo rm ation  of LDL 
p re in cu b a ted  w ith  m urine  fib rob lasts . LDL were preincubated 
with lacZ cells or 15-LO cells (clones 2, 8 , and 12) for 24 h in cysteine- 
free RPMI. LDL was then isolated from the medium by ultra centrifu­
gation and conjugated diene formation measured in the presence of 
2.5 pu  copper in a continuously recording spectrophotometer as 
described <22),
Table V
Ability of LDL conditioned by incubation with PA317 clones and then 
further oxidized by macrophages to compete with 1S5I-ox-LDL for
macrophage degradation
Unlabeled LDL was subjected to oxidative modification either by 
incubation with copper (5 /a m ) for 20 h in RPMI in the absence of cells 
or by incubation for 20 h in cysteine-free RPMI with the lacZ control 
clone or with clones 2, 8, and 12. The cell-conditioned LDL preparations 
were subsequently incubated for an additional 20 h with mouse perito­
neal macrophages in DME/RPMI (50:50) to effect a further oxidative 
stress. Each of these unlabeled, oxidized LDL preparations (25 /¿g/ml) 
was then tested for its ability to competitively inhibit the degradation of 
I25I-copper-oxidized LDL (2.5 /xg/ml) by mouse peritoneal macrophages 
in DME (20-h incubation). Each value is the average of duplicate 
determinations.
Competitor present 12r>I-ox-LDL degraded % inhibition
None
¡igimg call protein [20 h
20.1
1. Copper-oxidized LDL 6,1 70
2. LacZ-conditioned LDL 18.6 8
3. Clone 12-conditioned LDL 5.9 71
4. Clone 2-conditioned LDL 13.5 33
5. Clone 8-conditioned LDL 12.2 39
copper-mediated oxidation, as measured by conjugated diene 
formation, and by its greater ability to compete with 125I-ox- 
LDL for macrophage uptake, we could not demonstrate en­
hanced agarose gel electrophoretic mobility after 3, 6, or even 
18 h of copper exposure (data not shown), as compared to the 
lacZ conditioned LDL exposed to similar conditions. The reason 
for this dissociation is not known but it implies that a greater 
increase in net negative charge is not a sine qua non for recog­
nition by macrophage scavenger receptors.
DISCUSSION
These studies clearly show th a t when LDL was incubated 
with a cell line overexpressing 15-LO there was significantly 
greater seeding of that LDL with LOOH compared to LDL 
incubated with control cell line lacZ (Tables II and III). At the 
end of the first hour, the medium incubated with clone 12 
showed five to six times more LOOH than was found in me­
dium incubated with lacZ cells. However, the LOOH content of 
the medium did not increase linearly. Even in the incubations 
with clone 12, which showed the highest rate of LOOH buildup, 
the medium content of LOOH did not double between the end 
of the first hour and the end of the second hour (Table III). In
Table VI
Ability of LDL conditioned by incubation with PA317 clones and then 
further oxidized by incubation with copper to compete with
125I-ox-LDL for macrophage degradation
Unlabeled LDL was oxidized in various ways and then tested for its 
ability to compete with 12r,I-ox-LDL for degradation by mouse peritoneal 
macrophages. The unlabeled competitors include: 1) LDL incubated 
with 5 pM copper for 20 h in cysteine-free RPMI; 2-5) LDL preincubated 
with lacZ or with clones 12, 2, and 8, respectively, in RPMI for 20 h and 
then oxidized further by exposure to copper (5 pu) in RPMI for 3.5 h. 
13f,I-ox-LDL was prepared by incubation in the presence of 5 pM copper 
for 20 h in cysteine-free RPMI, It was added at 2.5 pgiml to mouse 
peritoneal macrophages along with 25 ^ g/ml of the unlabeled compet­
itor for 20 h in DME. Values are average of duplicate determinations 
and representative of four other experiments.
Competitor present 1MI-ox-LDL degraded % inhibition
None
Hg! mg call protein ¡20 h
6.53
1. Copper-oxidized LDL 2.53 61
2. LacZ-conditioned LDL 7.2 0
3, Clone 12-conditioned LDL 3.0 44
4. Clone 2-conditioned LDL 5.58 15
5. Clone 8-conditioned LDL 5.77 12
the case of the other two clones expressing 15-LO, there was 
actually less LOOH in the medium a t the end of the second 
hour. The reason for this decided non-linearity is not clear, but 
it has a great deal of relevance to the interpretation of the 
studies in which LDL was incubated for longer times with 
these cell lines. One would anticipate that the higher content of 
LOOH in LDL incubated with clone 12 would lead to a greater 
rate of subsequent oxidative modification. Indeed, LDL condi­
tioned by incubation with clone 12 had significantly greater 
rates of macrophage degradation than LDL conditioned by 
incubation with lacZ cells (p <  0.003) (Pig. 3). This was true 
despite the fact that the absolute rate of degradation of the 
LDL conditioned by the lacZ mouse fibroblasts was surpris­
ingly high. In some experiments it approached that seen with 
LDL modified by incubation with endothelial cells or macro­
phages. Thus, LDL incubated for 24 h with monolayers of 
mouse peritoneal macrophages is generally degraded at about 
7.5 pg/mg macrophage protein/5 h, and the rate for LDL con­
ditioned by endothelial cells is only slightly less than that. In 
fact, it is unusual to see degradation at a rate greater than 10 
jug/mg/5 h, even with copper-oxidized LDL. Thus, the values 
seen here with PA317 cells may be approaching a “ceiling,” In 
retrospect, the choice of these cells was not optimal for the 
present studies. Even though the wild-type cells contain no 
15-LO activity, they clearly contain other systems that can 
oxidize LDL at a brisk rate. Despite this, the addition of 15-LO 
increased the capacity of the cells to seed LDL in the medium 
with LOOH and make the LDL more susceptible to oxidative 
modification. O’Leary et aL (36) demonstrated directly that 
enrichment of LDL with lipid peroxides resulting from 15-LO 
activity led to propagation of LDL oxidation in the presence of 
transition metals. Similarly, we demonstrate here that an en­
hanced content of LOOH in LDL incubated with 15-LO cells 
also made these LDL more susceptible to modification when 
subsequently challenged with an oxidative stress.
Different LDL preparations can differ widely in their suscep­
tibility to oxidative modification (37, 38). Many factors contrib­
ute to that variability, including the progressive oxidation of 
LDL, even when stored at low temperatures. Kbouw et al. (22) 
have recently called attention to the way in which radioiodina- 
tion of LDL accentuates this oxidation during storage. LDL 
that has already been “seeded” with lipoperoxides (as a result 
of storage and/or iodination) will undergo significantly more 
rapid modification when subjected to oxidative stress, whether 
it be oxidation catalyzed by copper or oxidation catalyzed by
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cells. The fact that EDTA can inhibit macrophage-induced 
modification of LDL in F-10 medium (39) tells us th a t metal- 
catalyzed propagation in the medium is essential for maximum 
biological modification of LDL and that this probably rests on 
the presence of lipoperoxides seeded in the LDL itself. We 
believe tha t in our first studies (Fig. 3), in which the 15-LO 
cells had only a 2-fold greater ability to modify LDL, the results 
were strongly affected by artifactual oxidation of the substrate 
125I-LDL, i.e. the radiation-induced oxidation minimized differ­
ences th a t resulted from seeding by 15-LO cells. This is sup­
ported by comparison with the data in Tables V and VI showing 
results from later studies in which unlabeled LDL was used 
rather than 125I-LDL. The ability of such conditioned LDL to 
compete with copper-oxidized 12rT-LDL was studied rather 
than directly measuring the rate of degradation of conditioned 
12GI-LDL. Now the contrast between LDL conditioned by clone 
12 or by lacZ cells was much greater. In these studies, the 
unlabeled LDL was first seeded with hydroperoxides by incu­
bation with the PA317 clones, then subjected to an oxidative 
stress by incubation with macrophages, and finally tested for 
competition with 125I-ox-LDL. LacZ-conditioned unlabeled 
LDL showed only an 8% inhibition of the degradation of oxi­
dized 125I-LDL while clone 12-conditioned LDL inhibited by 
71%, a value similar to that achieved by unlabeled LDL oxi­
dized by exposure to copper (Table V). As shown in Table VI, 
similar results were obtained when the cell-conditioned unla­
beled LDL was incubated with copper for 3.5 h (instead of the 
preliminary macrophage incubation) before testing its ability 
to compete with I2RI-ox-LDL, In this instance, the lacZ- 
conditioned LDL showed no detectable inhibition while the 
clone 12-conditioned LDL inhibited by 44% (compared with 
61% for competition by unlabeled copper-oxidized LDL).
The precise mechanism(s) linking the increased cellular ex­
pression of 15-LO to the increased seeding of LDL with lipoper­
oxides is not established by these studies. One possibility is 
that 15-LO acts on endogenous lipids in the cell and th a t these 
are subsequently transferred to LDL in the medium. Addi­
tional possibilities are not ruled out, however. For example, 
while 15-LO is an intracellular enzyme, it might conceivably be 
able to act directly on LDL making contact with the cell’s 
surface or there might be increased generation of reactive 
oxygen species linked to the action of 15-LO, as suggested by 
the studies of Cathcart and co-workers (40).
These studies establish that cellular 15-LO has the potential 
to play a role in oxidative modification of LDL, Several lines of 
evidence compatible with such a role were briefly listed in the 
introduction. Perhaps the strongest evidence that it plays a 
role in vivo comes from the studies of Kühn et al. (14, 19), 
showing that the lipids in fatty streak lesions of cholesterol-fed 
rabbits contain a disproportionately high percentage of ste­
reo specifically derived hydroxy fatty acids. After 12 weeks of 
feeding, 73.7% of the 13-HODE was present in the S form 
(instead of the theoretical 50% if no enzymatic activity were 
involved). These findings, together with the previously re ­
ported finding that the 15-LO gene and its protein product are 
present at high levels in early lesions (15, 16), are compatible 
with a role of 15-LO in vivo but do not establish it. Ultimately, 
it may require studies in transgenic mice to assign the proper 
weight to 15-LO in the atherogenic process.
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